- About us
- Value, Pricing & Access
- Medical & Scientific Affairs
- Centers of Excellence
- Join Putnam
Our approach emphasizes rigor from start to finish, delivering thoughtful, fact-based answers to your most critical questions.
We bring a hypothesis-driven approach that uses a range of primary and secondary market research sources and approaches to deliver actionable insights tailored to your specific needs with market context.
Our strong relationships with in-country partners enable us to support nearly all life science markets and understand the nuances that impact insight gathering and methodological design. Our life science integrated insights expertise supports our core offerings.
Our life science integrated insights expertise supports our core offerings:
Global – Research in 50+ markets.
Diverse – Breadth of insights experience in therapeutic areas, disease subtypes, and stakeholder types.
Custom – Fit-for-purpose project methodology ensures focus on the right questions for the right answers.
Comprehensive – 200+ projects per year with the methodology to fit client needs. Qualitative, quantitative, and hybrid.
We are experts at identifying, collecting, and analyzing the appropriate insights to inform confident decision making.
Sr. Director of Insights
Brian leads Putnam’s primary integrated insights department and insights service offering development. He provides methodology and design expertise to Putnam case teams and operates in a project leadership and client development role. Brian has experience conducting research with stakeholders (both HCPs and Patients) across various therapeutic areas, using both qualitative and quantitative research methods. Brian also has deep experience with advanced quantitative methodologies (conjoint, segmentation, key drivers, agile research execution, etc.). Before joining Putnam, Brian’s research experience focused on innovation and product development for clients across industries including, medical device, diagnostics, tech, aerospace, automotive, and CPG.
Get the latest insights and perspectives from our experts.
Stay ahead in vaccine market strategy as competitor's halt forces Putnam's client to adapt global forecasts for dynamic launch scenarios.
The client with a focus on developing pipeline asset for KRAS G12C segment sought granular insights for competitive edge in treatment sequencing.
A large oncology company was looking to capitalize on early advantages in the cell therapy market. The organization engaged Putnam to support...